READ-ONLY DIGITIZATION RESULT
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
BMJ · 2025-Oct-29 · PMID 41224473
Panel Heart_failure_incidence_development_提取完成待 EXE 对齐验证
heart failure incidence
Fig 2 Cumulative hazard estimates and log-rank test of PREVENT-TAHA8 trial’s endpoints: heart failure (HF) incidence (development) (primary endpoint), readmission to hospital for HF, all cause mortality, cardiovascular mortality, readmission to hospital for myocardial infarction (MI), and composite endpoint of cardiovascular mortality and readmission to hospital for HF or MI. An interactive version of this graphic and downloadable data are available at https://public.flourish.studio/visualisation/25452455/
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T17:59:34+00:00 |